Deal Details

MIR Is Acquired by Quadrivio Silver Economy Fund and Minority Investors

Healthcare

MIR, a portfolio company of Aksìa and Overseas Industries, sale to Quadrivio and minority investors

Summary

Medical International Research (“MIR” or the “Company”), a portfolio company of Aksìa SGR (“Aksìa”) and Overseas Industries, has been acquired by Quadrivio Silver Economy Fund (“Quadrivio”) and a consortium of minority investors. Terms of the transaction were not disclosed.

Baird served as exclusive financial advisor to Aksìa, Overseas Industries (Aksìa's co-investor) and MIR's Founder, Siro Brugnoli, on this transaction.

About

MIR is a leading Italian producer of portable respiratory devices for professional and personal use. The Company was founded with the aim of promoting early diagnosis and the monitoring of major respiratory diseases. Today, MIR offers an integrated diagnostic platform that includes both medical devices (pulse oximeters, spirometers and single-use respiratory turbines) and proprietary software capable of real-time monitoring of key vital signs. MIR is headquartered in Rome, Italy.

Aksìa is a private equity fund management company that invests mainly in medium-sized Italian enterprises, fostering their growth, international development and process of managerial professionalisation. Aksìa, whose founding partners, Marco Rayneri and Nicola Emanuele, have been working together since 1997, have made over 60 transactions in Italy and abroad, investing more than €600 million through five funds. Aksìa is headquartered in Milan, Italy.

Quadrivio is a company active in alternative investments. Quadrivio has been operating for over 20 years in private equity and currently promotes and manages five thematic investment funds: Lifestyle Fund, Lifestyle Fund II, Industry 4.0 Fund, Silver Economy Fund and Artificial Intelligence PE Fund. These invest in Italian excellence, lifestyle, the digital transition for SMEs, the Silver Age and the integration and development of AI solutions, respectively. Quadrivio has offices in Luxembourg, London, Milan, New York, Los Angeles and Hong Kong. Quadrivio is headquartered in Milan, Italy.

Healthcare

MIR, a portfolio company of Aksìa and Overseas Industries, sale to Quadrivio and minority investors